Milestone

Milestones

2007

Foundation

2008

First trial batch taken

2009

Marketing operation started

2010

Introduced ASTRAL division ( 2nd Division )

2011

Introduced Donepezil (DOPEZIL ) : First time in Nepal
- WHO-GMP certificate
- Introduced PSYNO, a neuropsychiatric division

2012

Introduced Sitagliptin (GLIPTIN) – 1st time in Nepal

2013

Introduced Olmesartan (OSART) – 1st time in Nepal

2014

Received ISO 9001:2008 certificate

2014

Introduced VALID-ER – first Nepali brand of Divalproex Sodium

2015

Introduced MEGA division : Fourth division

2016

Introduced MEGA division : Fourth division

2017

Introduced MEGA division : Fourth division

2018

ENECA-B/ TENOF / MIXAR / GLIFAZ

2018

Institution division launched

2019

CDCU Ka and Kha segregated : - LUCAST PLUS launched

2020

Trade division

2021

Launching of novel oral anticoagulant COAGRIV , our brand of Rivaroxaban